Former Sen. Ben Sasse shines the spotlight on a possible breakthrough for pancreatic cancer

Revolution Medicines could be on the cusp of a breakthrough. The company expects to soon release results from a Phase 3 trial of its experimental drug that could become the first targeted treatment for pancreatic cancer, the deadliest of the major cancers. Just 13% of people with pancreatic cancer…